| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |